Press Contact
For media enquiries, please reach out to: contact@aspivix.com
All
- All
- Blog
- In the media
- Press releases
ASPIVIX Announces That Contraception, an International Reproductive Health Journal, Has Published First-In-Women Results Using Novel Cervical Stabilizer In IUD Procedures
Renens, Switzerland – 13 March 2023 – ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological and fertility care, today announced the publication of the results in Contraception, an...
Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer
Renens, Switzerland – 26 January 2023 – ASPIVIX SA, an innovator and developer of medical technologies to advance gynecological care, today announced that Carevix™, its novel Atraumatic Cervical Stabilizer, has received 510(k)...
ASPIVIX – Manufacturer of non-traumatic medical devices for gynecology – closes $5M Series A+ Funding Round and receives a large EUREKA-EUROSTARS grant co-funded by Innosuisse, the Swiss Innovation Agency.
This funding round will accelerate market access in Europe and US, and finance clinical activities in the US, while the EUREKA EUROSTARS grant will fuel R&D’s activities to expand product offering. ASPIVIX,...
10 Simple Steps Gynecologists Can Take to Enhance Patient Experience
A visit to the gynecologist can be a daunting experience for many women. There are a lot of unknowns and it can be an emotionally charged atmosphere. Gynecologists must be aware of...
5 Common Myths About Contraceptives
Contraceptives, like pills and condoms, are some of the most commonly used medications in the world. But despite their popularity, there are a lot of misconceptions about them. In this blog post,...
